PON2
- Known as:
- PON2
- Catalog number:
- ENZ-300
- Product Quantity:
- 2µg
- Category:
- -
- Supplier:
- Prospecbio
- Gene target:
- PON2
Related genes to: PON2
- Gene:
- PON2 NIH gene
- Name:
- paraoxonase 2
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 7q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1995-05-25
- Date modifiied:
- 2014-11-19
Related products to: PON2
A-esterase 2,Aromatic esterase 2,Bos taurus,Bovine,PON 2,PON2,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2A-esterase 2,Aromatic esterase 2,Canis familiaris,Canis lupus familiaris,Dog,PON 2,PON2,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2A-esterase 2,Aromatic esterase 2,Chicken,Gallus gallus,PON 2,PON2,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2A-esterase 2,Aromatic esterase 2,Homo sapiens,Human,PON 2,PON2,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2A-esterase 2,Aromatic esterase 2,Mouse,Mus musculus,PON 2,Pon2,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2A-esterase 2,Aromatic esterase 2,PON 2,Pon2,Rat,Rattus norvegicus,Serum aryldialkylphosphatase 2,Serum paraoxonase_arylesterase 2anti-PON2anti-PON2anti-PON2 (aa89-105)anti-PON2 (AF3E6)anti-PON2 (AF3E6)anti-PON2 (AF3E6) type: Primary antibodies host: Mouseanti-PON2 (AF3E6), Mouse monoclonal to PON2, Isotype IgG1, Host Mouseanti-PON2 (Paraoxonase 2), Rabbit polyclonal to PON2 (Paraoxonase 2), Isotype IgG, Host RabbitAnti-PON2 Antibody Related articles to: PON2
- Paraoxonase 2 (PON2) is an enzyme exhibiting both lactonase and esterase activities, widely distributed across various tissues and localized within cellular mitochondria. It plays a vital role in innate immunity by restricting bacterial infections and has diverse functions, including the regulation of mitochondrial reactive oxygen species levels and the management of endoplasmic reticulum stress. By alleviating oxidative stress, stabilizing mitochondria, and modulating apoptosis, PON2 emerges as a significant factor in the study of cellular senescence. This review consolidates recent findings regarding PON2's physiological roles, its mechanistic connections to senescence, and the therapeutic potential of modulating its activity. Our analysis highlights PON2's considerable promise as a target for aging-related diseases, including neurodegeneration, metabolic disorders, cardiovascular diseases, chronic inflammation, and cancer. - Source: PubMed
Publication date: 2026/04/29
Kim Hyeong HwanKang Ye JinLee Jae HoLee Hyeong MinPark Hyung SoonNam Chang-Hoon - This study aims to explore the potential molecular mechanisms by which di (2-ethylhexyl) phthalate (DEHP) exposure induces pulmonary arterial hypertension (PAH). - Source: PubMed
Publication date: 2026/03/20
Li HuaJiang YingchunLi Jijia - Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent and debilitating adverse effect associated with the use of different anticancer drugs such as platinum compounds, taxanes, vinca alkaloids, and proteasome inhibitors. In the current experimental study, we investigate the neuroprotective effects of umbelliferone against oxaliplatin (OXA)-induced peripheral neuropathy in rats. Intraperitoneal administration of OXA (4 mg/kg) was used for induction of neurotoxicity in the rats. The rats subsequently received the oral administration of umbelliferone at a dose of 2.5, 5, and 10 mg/kg. The mechanical withdrawal threshold (MWT), cold allodynia testing, nerve conduction activity, body weight, cerebrum weight, cerebrum index, acetylcholinesterase (AchE), total protein, nitric oxide (NO), antioxidant, inflammatory cytokines, apoptosis, and inflammatory parameters were estimated. The different mRNA expressions were measured in the brain tissue. Umbelliferone treatment improved the MWT and reduced the cold allodynia. Umbelliferone significantly (P < 0.001) improved the nerve conduction velocity, along with the body weight, cerebrum weight, cerebrum index, and altered the levels of acetylcholinesterase (AchE), total protein, and nitric oxide (NO). Umbelliferone treatment altered the level of antioxidant parameters (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH), malonaldehyde (MDA)); inflammatory cytokines (interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α), IL-10, IL-18); inflammatory parameters (cyclooxygenase-2 (COX-2), inducible nitric oxide synthetase (iNOS), prostaglandin E (PGE), nuclear factor kappa B (NF-κB)); apoptosis parameters (caspase-3, caspase-9, Bcl-2 Associated X protein (Bax), B-cell lymphoma 2 (Bcl-2), Bax/Bcl-2 ratio). Umbelliferone treatment altered the mRNA expression paraoxonase (PON)-1, PON-2, PON-3, and peroxisome proliferator-activated receptor δ (PPAR-δ). The findings clearly showed the neuroprotective effect of umbelliferone against OXA-induced neurotoxicity in rats via alteration of NF-κB, PPAR-δ, and mitochondrial apoptosis pathways. - Source: PubMed
Publication date: 2026/03/27
Li XiaohuiHan YuTian HanCheng ZihuiZuo JingjingShen Qingxia - The sodium-hydrogen exchanger-1 (NHE1) is a ubiquitously expressed transmembrane transporter that plays a central role in maintaining intracellular pH homeostasis and supporting normal cellular function. In cancer, NHE1 is overexpressed in many tumor types and has been associated with increased cancer cell metastasis and proliferation. Beyond these established roles, emerging evidence implicates NHE1 as a regulator of cancer cell metabolism. By driving intracellular alkalinization and shaping the tumor microenvironment, NHE1 influences metabolic pathway activity, mitochondrial function, redox balance, and cellular stress responses. In this review, we synthesize current evidence linking NHE1 dysregulation to metabolic reprogramming in cancer, with a focus on mitochondrial metabolism, glycolytic flux, lysosomal biology, and reactive oxygen species-associated stress pathways. We further evaluate pharmacological strategies targeting NHE1, emphasizing their metabolic consequences, translational potential, and the challenges that have limited clinical application to date. Collectively, this review highlights NHE1 as a potential integrator of ion transport and metabolic control in cancer and discusses how targeting NHE1-driven metabolic programs may support the development of novel therapeutic strategies. - Source: PubMed
Publication date: 2026/03/15
Al-Hamaly Majd AForester Beau RBlackburn Jessica S - A plethora of studies have demonstrated the pathophysiological roles played by paraxonase 2 (PON2) in oxidative stress control, inhibition of apoptosis, infections, and the progression of various types of malignancies. The continuous interest in PON2 has not gone hand in hand with the development of its inhibitors. Indeed, only one inhibitor for PON2, namely TQ416, is known, although neither its preparation nor a systematic structure-activity relationship analysis has been so far reported. Herein, we outline the first study aimed at the definition of structure-activity relationships of TQ416 by the preparation of a small library of its analogues. Successfully, we identified some [1,2,4]triazolo[4,3-]quinoline derivatives more potent than TQ416 as PON2 inhibitors, and among them one endowed with an IC value in the nanomolar range. We tested the parent TQ416 and its most effective congener in cells showing their effectiveness and complex behaviour. - Source: PubMed
Publication date: 2026/03/26
Bianconi ElisaLampitella Eros AntonioNigro FatimaRossi LudovicaZambri FedericoFava SimoneMarone MariaPorzio ElenaMacchiarulo AntonioManco GiuseppeMarinozzi Maura